News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HERSHBERG ROBERT
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/07/2023 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 03/08/2023 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 18,145 shares
@ $0
Granted 36,290 options to buy
@ $6.2, valued at
$225k
|
|
| 06/13/2022 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 18,000 options to buy
@ $4.18, valued at
$75.2k
|
|
| 06/13/2022 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 8,650 shares
@ $0
Granted 11,893 options to buy
@ $23.48, valued at
$279.2k
|
|
| 06/06/2022 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 672 shares
@ $22.75, valued at
$15.3k
|
|
| 04/18/2022 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Exercised 3,306 options to buy
@ $0 |
|
| 01/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 693 shares
@ $0 |
|
| 10/05/2021 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 572 shares
@ $0 |
|
| 09/21/2021 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $28.83, valued at
$432.5k
|
|
| 07/06/2021 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 347 shares
@ $0 |
|
| 06/17/2021 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Exercised 5,520 options to buy
@ $0
Granted 3,890 options to buy
@ $0 |
|
| 06/04/2021 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 2,681 shares
@ $0
Granted 4,334 options to buy
@ $68.94, valued at
$298.8k
|
|
| 04/22/2021 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Converted 6,250 shares
@ $0
Converted 12,500 options to buy
@ $18, valued at
$225k
Converted 525,000 options to buy
@ $2.22, valued at
$1.2M
|
|
| 04/19/2021 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 6,250 shares
@ $0
Granted 12,500 options to buy
@ $18, valued at
$225k
|
|
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Sold 4 shares
@ $63.58, valued at
$254.3
Sold 282 shares
@ $66.03, valued at
$18.6k
Sold 1,214 shares
@ $67.16, valued at
$81.5k
Exercised 1,500 options to buy
@ $11.2, valued at
$16.8k
|
|
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 1,378 shares
@ $66.34, valued at
$91.4k
Sold 622 shares
@ $67.05, valued at
$41.7k
Exercised 2,000 options to buy
@ $0.45, valued at
$900 |
|
| 01/19/2021 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Sold 709 shares
@ $71.77, valued at
$50.9k
Sold 410 shares
@ $72.91, valued at
$29.9k
Sold 291 shares
@ $73.66, valued at
$21.4k
Sold 90 shares
@ $74.55, valued at
$6.7k
Exercised 1,500 options to buy
@ $11.2, valued at
$16.8k
|
|
| 12/16/2020 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 1,759 shares
@ $55.78, valued at
$98.1k
Sold 241 shares
@ $57.01, valued at
$13.7k
Exercised 2,000 options to buy
@ $0.45, valued at
$900 |
|
| 12/16/2020 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Sold 688 shares
@ $68.68, valued at
$47.3k
Sold 812 shares
@ $69.88, valued at
$56.7k
Exercised 1,500 options to buy
@ $11.2, valued at
$16.8k
|
|
| 12/07/2020 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 73,251 options to buy
@ $21, valued at
$1.5M
|
|
| 11/18/2020 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 1,777 shares
@ $47.6, valued at
$84.6k
Sold 223 shares
@ $48.41, valued at
$10.8k
Exercised 2,000 options to buy
@ $0.45, valued at
$900 |
|
| 11/18/2020 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Sold 754 shares
@ $46.31, valued at
$34.9k
Sold 746 shares
@ $47.03, valued at
$35.1k
Exercised 1,500 options to buy
@ $11.2, valued at
$16.8k
|
|
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2020 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Sold 1,337 shares
@ $43.55, valued at
$58.2k
Sold 163 shares
@ $44.2, valued at
$7.2k
Exercised 1,500 options to buy
@ $11.2, valued at
$16.8k
|
|
|
|
|